Literature DB >> 23207787

The risk of hardware infection in deep brain stimulation surgery is greater at impulse generator replacement than at the primary procedure.

Joshua Pepper1, Ludvic Zrinzo, Bilal Mirza, Thomas Foltynie, Patricia Limousin, Marwan Hariz.   

Abstract

BACKGROUND/AIMS: Infection of implanted hardware after deep brain stimulation (DBS) has a significant impact on patient morbidity. We examined all patients who underwent DBS procedures over the last 9 years in our centre to assess the infection rate and possible factors related to surgery that may predispose to infection.
METHODS: Surgical reports and clinical notes were reviewed in 273 consecutive patients who underwent a total of 519 DBS-related procedures in our institute between November 2002 and September 2011.
RESULTS: Sixteen separate hardware-related infections occurred in 11 patients. Infections occurred in 3% of all procedures and 4% of all patients. The infection rate after implantable pulse generator (IPG) replacement surgery was more than three times higher than after de novo DBS surgery. In addition, male patients were more likely to develop device-related infections.
CONCLUSIONS: It is unclear why infection rates should be more than three times higher after IPG replacement surgery than after the de novo procedure. The former is a shorter and simpler procedure to conduct. Perhaps the use of better antimicrobial protection and rechargeable batteries may be useful strategies to reduce infections following IPG revision surgery.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23207787     DOI: 10.1159/000343202

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  26 in total

Review 1.  Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.

Authors:  Giovanni Cossu; Mariachiara Sensi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

2.  Once STN DBS, Always STN DBS?-Clinical, Ethical, and Financial Reflections on Deep Brain Stimulation for Parkinson's Disease.

Authors:  Marwan Hariz
Journal:  Mov Disord Clin Pract       Date:  2016-02-11

3.  Deep brain stimulation as a treatment for chorea-acanthocytosis.

Authors:  Zinovia Kefalopoulou; Ludvic Zrinzo; Iciar Aviles-Olmos; Kailash Bhatia; Paul Jarman; Marjan Jahanshahi; Patricia Limousin; Marwan Hariz; Thomas Foltynie
Journal:  J Neurol       Date:  2012-10-20       Impact factor: 4.849

4.  Neurosurgery: Psychosurgery guidelines--friction between ideal and reality?

Authors:  Veerle Visser-Vandewalle
Journal:  Nat Rev Neurol       Date:  2014-04-22       Impact factor: 42.937

5.  Deep brain stimulation hardware-related infections: 10-year experience at a single institution.

Authors:  Kingsley O Abode-Iyamah; Hsiu-Yin Chiang; Royce W Woodroffe; Brian Park; Francis J Jareczek; Yasunori Nagahama; Nolan Winslow; Loreen A Herwaldt; Jeremy D W Greenlee
Journal:  J Neurosurg       Date:  2018-03-01       Impact factor: 5.115

6.  Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders.

Authors:  Kyle T Mitchell; Monica Volz; Aaron Lee; Marta San Luciano; Sarah Wang; Philip A Starr; Paul Larson; Nicholas B Galifianakis; Jill L Ostrem
Journal:  Stereotact Funct Neurosurg       Date:  2019-07-09       Impact factor: 1.875

7.  Care Bundle Approach to Minimizing Infection Rates after Neurosurgical Implants for Neuromodulation: A Single-Surgeon Experience.

Authors:  Elsa V Arocho-Quinones; Chiang-Ching Huang; Barney D Ward; Peter A Pahapill
Journal:  World Neurosurg       Date:  2019-04-12       Impact factor: 2.104

8.  Optimized temporal pattern of brain stimulation designed by computational evolution.

Authors:  David T Brocker; Brandon D Swan; Rosa Q So; Dennis A Turner; Robert E Gross; Warren M Grill
Journal:  Sci Transl Med       Date:  2017-01-04       Impact factor: 17.956

Review 9.  Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature.

Authors:  Christoph van Riesen; Georg Tsironis; Doreen Gruber; Fabian Klostermann; Patricia Krause; Gerd Helge Schneider; Andreas Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2016-05-19       Impact factor: 3.575

10.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.